相关实验视频

Updated: Jul 2, 2025

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Functional Reconstitution and Channel Activity Measurements of Purified Wildtype and Mutant CFTR Protein

Published on: March 9, 2015

通过CFTR_inh-172抑制CFTR的结构基础

Paul G Young^1,2, Jesper Levring¹, Karol Fiedorczuk¹

¹Laboratory of Membrane Biology and Biophysics, The Rockefeller University, New York, NY 10065.

Proceedings of the National Academy of Sciences of the United States of America

|February 29, 2024

概括

研究人员阐明了CFTR_inh-172的机制,CFTR是一种囊性纤维化转膜导电调节器 (CFTR) 抑制剂. 这项研究揭示了CFTR-172通过稳定化物选择性过器的崩来阻断通道孔,从而提供了对CFTR抑制的见解.

科学领域:

分子生物学分子生物学
结构生物学结构生物学
生物物理学的生物物理.

背景情况:

囊性纤维化转膜导电调节器 (CFTR) 对电解质和液体平衡至关重要.
CFTR激活治疗囊性纤维化,而其抑制则是分泌性腹和多囊性病的治疗标.
许多CFTR抑制剂的确切作用机制尚不清楚.

研究的目的:

为了确定CFTR与抑制剂CFTR_inh-172.172复合的结构.
阐明CFTR_inh-172抑制CFTR通道活性的分子机制.
为广泛使用的CFTR抑制剂的功能提供结构基础.

主要方法:

低温电子显微镜 (cryo-EM) 用于确定CFTR-CFTR_inh-172复合物的高分辨率结构.
单分子光共振能量转移 (smFRET) 实验,以评估通道关和核酸结合域二分化.

主要成果:

2.7 Å的冷-EM结构揭示了CFTR_inh-172在外膜螺旋8.附近的CFTR孔内结合.
CFTR_inh-172结合稳定了与化物选择性过器崩的形状,从细胞外侧阻断了孔隙.
smFRET实验证实,CFTR_inh-172抑制了通道关,而不会影响核酸结合域二分化.

结论:

这项研究提供了对CFTR_inh-172结合和抑制的详细分子理解.
这些发现协调了先前的生物物理数据,并解释了这种CFTR抑制剂的机制.
这种结构性洞察对于合理设计新型CFTR向治疗方法至关重要.

关键词:

在CFTR中,CFTR是最重要的.抑制剂抑制剂的使用离子通道离子通道离子通道

更多相关视频

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes

In Vitro Analysis of PDZ-dependent CFTR Macromolecular Signaling Complexes

Published on: August 13, 2012

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

相关概念视频

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...